In cirrhosis, both CD169+ and CD169− monocytes had increased surface expression of CD64 in comparison with healthy controls, while CD169+ monocytes had higher expression than CD169− monocytes (Fig. 2d). The gene discussed is FCGR1A; the disease is Cirrhosis.